Cart
sales@molnova.com
Rocepafant
CAS No. 132579-32-9
Rocepafant( —— )
Catalog No. M34402 CAS No. 132579-32-9
Rocepafant (LAU8080) is a platelet-activating factor (PAF) antagonist that attenuates hypoxic-ischemic brain damage in neonatal rats.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 101 | In Stock |
|
| 10MG | 148 | In Stock |
|
| 25MG | 288 | In Stock |
|
| 50MG | 384 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRocepafant
-
NoteResearch use only, not for human use.
-
Brief DescriptionRocepafant (LAU8080) is a platelet-activating factor (PAF) antagonist that attenuates hypoxic-ischemic brain damage in neonatal rats.
-
DescriptionRocepafant (LAU8080) is a platelet-activating factor (PAF) antagonist that attenuates hypoxic-ischemic brain damage in neonatal rats.Rocepafant inhibits tumor necrosis factor-Afa-mediated cytotoxicity in mouse L929 tumor cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetPlatelet aggregation
-
RecptorPlatelet aggregation
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number132579-32-9
-
Formula Weight535.08
-
Molecular FormulaC26H23ClN6OS2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC=1N2C3=C(C4=C(S3)CN(C(NC5=CC=C(OC)C=C5)=S)CC4)C(=NCC2=NN1)C6=C(Cl)C=CC=C6
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Suloctidil
Suloctidil is a new drug that is currently being evaluated in many clinical trials for use in dementia and thrombotic disorders.
-
Carbasalate?Calcium
Carbasalate calcium?is an?analgesic,?antipyretic, and?anti-inflammatory?drug,?as well as a?platelet aggregation inhibitor.?
-
Mutant EGFR inhibito...
Mutant EGFR inhibitor is a selective and potent Mutated EGFR inhibitor, inhibits L858R activating mutant, the Exonl9 deletion activating mutant and the T790M resistance mutant.
